Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-26T18:15:53.000Z thumbnail image
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-24T16:27:02.000Z thumbnail image
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0 and now includes 6 locations, replacing the previous version v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T14:55:00.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-07-20T10:47:57.000Z thumbnail image
  7. Check
    8 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-19T10:01:41.000Z thumbnail image
  8. Check
    10 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-07-17T08:15:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.